Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Equity (2016 - 2025)

Historic Return on Equity for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to 0.03%.

  • Usana Health Sciences' Return on Equity fell 700.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.08% for FY2024, which is 600.0% down from last year.
  • Per Usana Health Sciences' latest filing, its Return on Equity stood at 0.03% for Q3 2025, which was down 700.0% from 0.07% recorded in Q2 2025.
  • Usana Health Sciences' 5-year Return on Equity high stood at 0.24% for Q3 2021, and its period low was 0.03% during Q3 2025.
  • Its 5-year average for Return on Equity is 0.15%, with a median of 0.15% in 2022.
  • As far as peak fluctuations go, Usana Health Sciences' Return on Equity crashed by -1200bps in 2022, and later soared by 300bps in 2023.
  • Over the past 5 years, Usana Health Sciences' Return on Equity (Quarter) stood at 0.24% in 2021, then dropped by -20bps to 0.19% in 2022, then decreased by -30bps to 0.13% in 2023, then crashed by -40bps to 0.08% in 2024, then crashed by -58bps to 0.03% in 2025.
  • Its Return on Equity was 0.03% in Q3 2025, compared to 0.07% in Q2 2025 and 0.07% in Q1 2025.